Connection

Co-Authors

This is a "connection" page, showing publications co-authored by Sho Saito and Noriko Kinoshita.
Connection Strength

1.019
  1. How we secured a COVID-19 convalescent plasma procurement scheme in Japan. Transfusion. 2021 07; 61(7):1998-2007.
    View in: PubMed
    Score: 0.059
  2. Clinical course of alopecia after COVID-19. Int J Infect Dis. 2021 06; 107:255-256.
    View in: PubMed
    Score: 0.059
  3. Positive Ratio of Polymerase Chain Reaction (PCR) and Validity of Pre-Screening Criteria at an Outpatient Screening Center during the Early Phase of the COVID-19 Epidemic in Japan. Jpn J Infect Dis. 2021 Sep 22; 74(5):481-486.
    View in: PubMed
    Score: 0.058
  4. Factors associated with anti-SARS-CoV-2 IgG antibody production in patients convalescing from COVID-19. J Infect Chemother. 2021 Jun; 27(6):808-813.
    View in: PubMed
    Score: 0.058
  5. No SARS-CoV-2 RNA detected in the convalescent plasma of COVID-19 patients with different disease severity. J Infect Chemother. 2021 Apr; 27(4):653-655.
    View in: PubMed
    Score: 0.058
  6. Telephone consults at the Infectious Disease Outpatient Clinic during the early period of the COVID-19 epidemic. Glob Health Med. 2020 Dec 31; 2(6):392-394.
    View in: PubMed
    Score: 0.058
  7. Non-COVID-19 Patients with Life-threatening Diseases Who Visited a Fever Clinic: A Single-center, Observational Study in Tokyo, Japan. Intern Med. 2020 Dec 15; 59(24):3131-3133.
    View in: PubMed
    Score: 0.057
  8. Environmental surface and air contamination in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) patient rooms by disease severity. Infect Prev Pract. 2020 Dec; 2(4):100098.
    View in: PubMed
    Score: 0.057
  9. Serum CCL17 level becomes a predictive marker to distinguish between mild/moderate and severe/critical disease in patients with COVID-19. Gene. 2021 Jan 15; 766:145145.
    View in: PubMed
    Score: 0.056
  10. Effectiveness of personal protective equipment in preventing severe acute respiratory syndrome coronavirus 2 infection among healthcare workers. J Infect Chemother. 2021 Jan; 27(1):120-122.
    View in: PubMed
    Score: 0.056
  11. Evaluation of Coronavirus Disease 2019 Severity Using Urine Biomarkers. Crit Care Explor. 2020 Aug; 2(8):e0170.
    View in: PubMed
    Score: 0.056
  12. Possibility of transmission of severe acute respiratory syndrome coronavirus 2 in a tertiary care hospital setting: A case study. Infect Prev Pract. 2020 Sep; 2(3):100079.
    View in: PubMed
    Score: 0.056
  13. COVID-19 can suddenly become severe: a case series from Tokyo, Japan. Glob Health Med. 2020 Jun 30; 2(3):174-177.
    View in: PubMed
    Score: 0.056
  14. SARS-CoV-2 Screening Test for Japanese Returnees From Wuhan, China, January 2020. Open Forum Infect Dis. 2020 Jul; 7(7):ofaa243.
    View in: PubMed
    Score: 0.056
  15. Difficulty of downscaling the precautions for coronavirus disease-19 based on negative throat polymerase chain results in the early phase of infection. J Infect Chemother. 2020 Aug; 26(8):851-853.
    View in: PubMed
    Score: 0.055
  16. SARS-CoV-2 infection among returnees on charter flights to Japan from Hubei, China: a report from National Center for Global Health and Medicine. Glob Health Med. 2020 Apr 30; 2(2):107-111.
    View in: PubMed
    Score: 0.055
  17. Psychiatric burdens or stress during hospitalization and concerns after discharge in patients with severe acute respiratory syndrome coronavirus-2 isolated in a tertiary care hospital. Psychiatry Res. 2020 07; 289:113040.
    View in: PubMed
    Score: 0.055
  18. Psychiatric burdens or stress during hospitalization and concerns after discharge in patients with severe acute respiratory syndrome coronavirus-2 isolated in a tertiary care hospital. Psychiatry Res. 2020 Apr 29; 289:113040.
    View in: PubMed
    Score: 0.055
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.